Thursday, November 26, 2009

ADHD Home>
ADHD News>
FDA delays extended-release Intuniv

Font size
- A
- A
- A
Email This

Bookmark

Save

FDA delays extended-release Intuniv

(Reuters) UPDATED 2009-07-29

The U.S. Food and Drug Administration (FDA) has delayed release of the extended-release ADHD medication Intuniv. According to drugmaker Shire, lengthy labeling discussions caused the FDA to miss their original target date of July. Shire said the FDA had not identified any safety concerns, and the company believes the drug will be released by the end of 2009. If given final approval, Intuniv will become the first selective alpha-2A receptor agonist released for the treatment of ADHD. Read full story >

See all ADHD News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on ADHDCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.